Current epidemiology of Staphylococcus aureus with decreased susceptibility to glycopeptides (vancomycin and teicoplanin) in France

Author(s): Allouch PY, Astagneau P, Aubry Damon H, Bismuth R, Brun Buisson C, Buu Hoi A, Carlet J, Chesneau O, Chaperon J, Courvalin P, Desenclos JC, Drucker J, Drugeon H, El Solh N, Etienne J, Fabry J, Gutmann L, Jarlier V, Joly C, Kac G, Leclercq R, Legrand P, Mainardi JL, Meunier O, Parneix P, Pierre V, Podglajen I, Ploy MC, Rauss A, Reverdy ME, Savey A, Soussy CJ, Struelens M, Tran B

Publishing year: 2000

In relation to

Our latest news

news

Call for Applications for the Renewal of the Editorial Board of the Weekly...

news

Traveling to Overseas Territories and Abroad: Are Your Vaccinations Up to Date?

news

Public Health France Conference: November 9, 2026